Valuation: Bio-Rad Laboratories, Inc.

Market Cap 9.85B 8.75B 8.16B 7.44B 14.03B 949B 14.17B 98.91B 38.34B 484B 36.98B 36.18B 1,555B P/E 2026 *
44.4x
P/E 2027 * 43.4x
Enterprise Value 9.1B 8.09B 7.54B 6.87B 12.97B 876B 13.09B 91.39B 35.42B 447B 34.17B 33.42B 1,436B EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.39x
Free-Float
60.17%
Yield 2026 *
-
Yield 2027 * -
1 day+3.82%
1 week-3.11%
Current month-2.27%
1 month-4.99%
3 months+24.35%
6 months+31.84%
Current year+21.83%
1 week 353.3
Extreme 353.3
383.95
1 month 353.3
Extreme 353.3
390.73
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
798.97
10 years 154.89
Extreme 154.89
832.7
Manager TitleAgeSince
Chief Executive Officer 76 01/01/2003
President 61 09/09/2024
Director of Finance/CFO 55 15/04/2024
Director TitleAgeSince
Chairman 76 01/01/2012
Director/Board Member 73 25/04/2017
Director/Board Member 79 25/04/2017
Date Insider Type Main position Quantity % Market Cap. Importance
9/6/26 A Exercice

General Counsel

1,841 0.0085%
9/6/26 A Exercice

Chief Executive Officer

8,764 0.0404%
9/6/26 A Exercice

Chief Financial Officer

3,854 0.0178%
Change 5-day change 1-year change 3-year change Capi.($)
+3.82%-3.11%+25.46%+5.00% 9.85B
+0.84%-3.74%-26.69%+1.85% 169B
-0.07%-2.55%-9.53%+11.07% 110B
+0.90%+1.13%-24.83%+0.58% 106B
-1.24%-0.76%-49.04%-12.75% 73.87B
-0.24%+0.69%+0.16%+72.58% 58.98B
-0.86%+2.96%+13.57%+59.50% 51.28B
-0.71%-3.82%-7.72%-31.41% 48.16B
+0.12%-0.17%-18.21%+20.29% 40.84B
-1.01%-1.45%+28.48%-9.72% 32.21B
Average +0.16%-1.08%-6.84%+11.70% 70B
Weighted average by Cap. +0.08%-1.32%-15.77%+10.05%

Financials

2026 *2027 *
Net sales 2.57B 2.28B 2.13B 1.94B 3.66B 247B 3.7B 25.8B 10B 126B 9.65B 9.44B 406B 2.62B 2.33B 2.17B 1.98B 3.74B 253B 3.77B 26.35B 10.21B 129B 9.85B 9.64B 414B
Net income 225M 200M 186M 170M 320M 21.65B 323M 2.26B 875M 11.04B 844M 826M 35.49B 230M 204M 190M 173M 327M 22.12B 330M 2.31B 894M 11.28B 862M 844M 36.26B
Net Debt -749M -666M -621M -566M -1.07B -72.13B -1.08B -7.52B -2.92B -36.78B -2.81B -2.75B -118B -965M -858M -800M -729M -1.38B -92.97B -1.39B -9.7B -3.76B -47.41B -3.62B -3.55B -152B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
02/10/26 $369.14 +3.82% 223,646
01/10/26 $355.57 -5.86% 264,583
30/09/26 $377.71 -0.48% 228,588
29/09/26 $379.55 +0.49% 261,682
28/09/26 $377.69 -0.87% 272,636
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
369.14USD
Average target price
328.33USD
Spread / Average Target
-11.05%

Quarterly revenue - Rate of surprise